Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM
Qian, Y., Hauber, A., Gonzalez, J., Posner, J., Mohamed, A., Tombal, B., Body, JJ., Gatta, F., & Arellano, J. (2014). Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM. Journal of Clinical Oncology, 32(4, Suppl.), Abstract 117.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.